NEW UPDATE NEURALINK! ELON MUSK REVEALS NEXT MAJOR PLAN FOR THIRD HUMAN TRIALS! HOW BLINDSIGHT WORK?

EV Channels Review

This video provides an in-depth update on Neuralink's human trials, focusing on the progress of the first two patients and the upcoming third trial. The first patient, Noland Arbaugh, experienced initial success with the first-generation chip, enabling thought-based control of devices, but later faced a significant malfunction due to thread retraction. Neuralink successfully addressed this by modifying algorithms and improving implantation techniques. The second patient, Alex, received an improved chip with double the threads and deeper implantation, demonstrating faster signal activation and enhanced capabilities, including advanced gaming and CAD design. The video also elaborates on the potential of Neuralink's 'Blindsight' product, aiming to restore vision through direct visual cortex stimulation, albeit initially at low resolution. While acknowledging the experimental nature and challenges, the review highlights Neuralink's ambitious vision for human augmentation and overcoming disabilities.